Opportunity Information: Apply for RFA HD 10 005
Apply for RFA HD 10 005
- The National Institutes of Health in the health income security and social services sector is offering a public funding opportunity titled "Postdoctoral Research Training in Pediatric Clinical and Developmental Pharmacology (T32)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.865 Child Health and Human Development Extramural Research.
- This funding opportunity was created on Apr 30, 2010 and posted on Apr 30, 2010.
- Applicants must submit their applications by Aug 3, 2010. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Native American tribal governments (Federally recognized) Private institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification) Public and State controlled institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This funding opportunity (RFA-HD-10-005) is an NIH Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (T32) focused on building a strong pipeline of clinician-scientists in pediatric clinical and developmental pharmacology. Run through the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), it supports institutions that want to create or strengthen structured postdoctoral research training programs designed to produce future leaders in pediatric clinical pharmacology research. The broader NIH goal behind the T32 mechanism is workforce development: ensuring the United States has a diverse, highly trained group of researchers prepared to take on leadership roles across the biomedical, behavioral, and clinical research landscape, with an emphasis on careers that meaningfully address national health research needs.
The core intent of this specific announcement is to help institutions train clinicians to become independent investigators in pediatric pharmacology. Programs supported under this FOA are expected to provide trainees with rigorous preparation in the methods and conduct of both basic and clinical research, so that graduates can design and carry out high-quality studies on their own. In practical terms, the emphasis is not just on clinical exposure, but on deep research skill-building: developing the ability to ask impactful questions, use appropriate study designs and analytic approaches, and generate evidence that can improve how medications are studied, dosed, and used in children as they grow and develop.
The mechanism of support is explicitly the NRSA T32 institutional training grant, meaning the award is made to an eligible organization rather than directly to an individual fellow. The institution then runs the training program and appoints trainees under the grant according to NRSA rules and the program structure proposed in the application. This is categorized as a discretionary grant within the Health, Income Security, and Social Services activity area, and it is associated with CFDA number 93.865 (Child Health and Human Development Extramural Research).
In terms of funding, NICHD projected approximately $350,000 in total costs (including both direct costs and facilities and administrative costs) in fiscal year 2011 for this initiative, with the expectation of making up to two new awards. As with many NIH opportunities, the actual number of awards and final funding depend on the availability of appropriated funds and whether enough applications meet a high merit threshold in peer review.
Eligibility is broad and includes a range of higher education institutions and organizations. Eligible applicants include public and state-controlled institutions of higher education, private institutions of higher education, and several nonprofit categories (including nonprofits with 501(c)(3) status and certain nonprofits without 501(c)(3) status, as described in the announcement). The eligibility list also explicitly includes multiple institution types that serve or are governed by historically underrepresented communities and U.S. jurisdictions, such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, U.S. territories or possessions, and certain tribal governments and tribal organizations. Faith-based or community-based organizations are also included among eligible applicants as described in the additional eligibility information.
Key dates included in the listing show the opportunity was posted on April 30, 2010, with an application closing date of August 3, 2010, and an archive date of September 3, 2010. The full announcement was hosted through the NIH grants guide, and technical assistance for access and linking issues was routed to the NIH Office of Extramural Research (OER) webmaster contact listed in the notice.
Frequently Asked Questions (FAQs)
What is this funding opportunity?
This opportunity is NIH RFA-HD-10-005, a Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (T32). It supports institutions that want to create or strengthen a structured postdoctoral research training program focused on pediatric clinical and developmental pharmacology.
Which NIH institute is running this program?
The program is run through the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
What is the main goal of this T32 training program?
The core intent is to build a strong pipeline of clinician-scientists by training clinicians to become independent investigators in pediatric pharmacology, with the long-term aim of producing future leaders in pediatric clinical pharmacology research.
Is the emphasis more clinical training or research training?
The emphasis is on deep research skill-building. Programs are expected to provide rigorous preparation in the methods and conduct of both basic and clinical research so trainees can design and carry out high-quality independent studies.
What kinds of research capabilities should trainees gain through the program?
Supported programs are expected to develop trainees who can ask impactful research questions, select appropriate study designs and analytic approaches, and generate evidence that improves how medications are studied, dosed, and used in children as they grow and develop.
What does "NRSA T32 institutional training grant" mean?
It means the award is made to an eligible organization (not directly to an individual). The institution operates the training program and appoints trainees under the grant according to NRSA rules and the program structure proposed in the application.
Who is the applicant: the trainee or the institution?
The applicant is the institution or organization applying to run the training program. Trainees are appointed by the institution after the grant is awarded.
What is the NIH’s broader goal behind using the T32 mechanism?
The broader NIH goal is workforce development: ensuring the United States has a diverse, highly trained research workforce prepared for leadership roles across biomedical, behavioral, and clinical research, with an emphasis on careers that address national health research needs.
How much funding is available under this opportunity?
NICHD projected approximately $350,000 in total costs (including both direct costs and facilities and administrative costs) in fiscal year 2011 for this initiative.
How many awards did NICHD expect to make?
NICHD expected to make up to two new awards, subject to the availability of appropriated funds and the number of applications that meet a high merit threshold in peer review.
Are the projected funding level and award count guaranteed?
No. As noted in the listing, the actual number of awards and final funding depend on appropriated funds and whether enough applications score highly in peer review.
What type of grant category is this opportunity listed under?
It is categorized as a discretionary grant within the Health, Income Security, and Social Services activity area.
What is the CFDA number associated with this opportunity?
The opportunity is associated with CFDA number 93.865, titled Child Health and Human Development Extramural Research.
Which organizations are eligible to apply?
Eligibility includes public and state-controlled institutions of higher education, private institutions of higher education, and several nonprofit categories (including certain 501(c)(3) nonprofits and certain nonprofits without 501(c)(3) status, as described in the announcement).
Are institutions serving historically underrepresented communities explicitly included as eligible applicants?
Yes. The eligibility list explicitly includes institution types that serve or are governed by historically underrepresented communities and U.S. jurisdictions, including HBCUs, Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, U.S. territories or possessions, and certain tribal governments and tribal organizations.
Are faith-based or community-based organizations eligible to apply?
Yes. Faith-based or community-based organizations are included among eligible applicants as described in the additional eligibility information.
What is the focus area of the training program supported by this RFA?
The focus is pediatric clinical and developmental pharmacology, with an emphasis on developing clinician-scientists who can lead pediatric clinical pharmacology research.
What are the key dates for this funding opportunity?
The opportunity was posted on April 30, 2010. The application closing date was August 3, 2010. The archive date was September 3, 2010.
Where was the full announcement hosted?
The full announcement was hosted through the NIH grants guide.
Who was listed as the technical assistance contact for access and linking issues?
Technical assistance for access and linking issues was routed to the NIH Office of Extramural Research (OER) webmaster contact listed in the notice.
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Health Income Security and Social Services
Next opportunity: Increase Awareness of Alveolar Capillary Dysplasia (ACD) Among Health Care Providers
Previous opportunity: Surveillance of Neural Tube Defects (NTDs) and Other Birth Defects in Low and Middle Income Countries
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA HD 10 005
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA HD 10 005) also looked into and applied for these:
| Funding Opportunity |
|---|
| Vulvodynia Systematic Epidemiologic, Etiologic or Therapeutic Studies (R01) Apply for PAR 10 190 Funding Number: PAR 10 190 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Vulvodynia Systematic Epidemiologic, Etiologic or Therapeutic Studies (R21) Apply for PAR 10 192 Funding Number: PAR 10 192 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Vulvodynia Systematic Epidemiologic, Etiologic or Therapeutic Studies (R03) Apply for PAR 10 191 Funding Number: PAR 10 191 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Natural History of Disorders Identifiable by Newborn Screening (R01) Apply for RFA HD 10 019 Funding Number: RFA HD 10 019 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $1,000,000 |
| Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Predoctoral Training Program in Systems Biology of Developmental Biology and Birth Defects(T32) Apply for PAR 10 193 Funding Number: PAR 10 193 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Predoctoral and Postdoctoral Training Program in Reproductive, Obstetric, Perinatal and Pediatric Epidemiology and Pharmacoepidemiology (T32) Apply for PAR 10 194 Funding Number: PAR 10 194 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Postdoctoral Research Training for Obstetricians and Gynecologists (T32) Apply for PAR 10 203 Funding Number: PAR 10 203 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Biophysical and Biomechanical Aspects of Embryonic Development (R21) Apply for PAR 10 222 Funding Number: PAR 10 222 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $200,000 |
| Biophysical and Biomechanical Aspects of Embryonic Development (R01) Apply for PAR 10 221 Funding Number: PAR 10 221 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Safe and Effective Instruments and Devices for Use in the Neonatal Intensive Care Units (SBIR R43) Apply for RFA HD 10 012 Funding Number: RFA HD 10 012 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $225,000 |
| Safe and Effective Instruments and Devices for Use in the Neonatal Intensive Care Units (STTR R41) Apply for RFA HD 10 013 Funding Number: RFA HD 10 013 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $225,000 |
| Innovative Therapies and Tools for Screenable Disorders in Newborns (R03) Apply for PAR 10 231 Funding Number: PAR 10 231 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Developmental Mechanisms of Human Structural Birth Defects (P01) Apply for RFA HD 10 006 Funding Number: RFA HD 10 006 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $900,000 |
| NICHD Program Project Grant (P01) Apply for PAR 10 245 Funding Number: PAR 10 245 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Molecular Mechanisms of Adverse Metabolic Drug Effects in Children and Adolescents (R01) Apply for RFA HD 10 010 Funding Number: RFA HD 10 010 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $250,000 |
| Dual Purpose with Dual Benefit Research in Biomedicine and Agriculture Using Agriculturally Important Domestic Species (R01) Apply for PAR 10 276 Funding Number: PAR 10 276 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Identifying and Understanding Effective Interventions for Orphans and Vulnerable Children Affected by HIV/AIDS (R01) Apply for RFA HD 10 017 Funding Number: RFA HD 10 017 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Preclinical Research on Model Organisms to Predict Treatment Outcomes for Disorders Associated with Intellectual and Developmental Disabilities (R01) Apply for PAR 11 038 Funding Number: PAR 11 038 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Understanding and Treating Co Morbid Conditions in Adolescents with Intellectual and Developmental Disabilities (R01) Apply for PA 11 039 Funding Number: PA 11 039 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Understanding and Treating Co Morbid Conditions in Adolescents with Intellectual and Developmental Disabilities (R03) Apply for PA 11 040 Funding Number: PA 11 040 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA HD 10 005", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.